Blueberries and oats could be the future of diabetes treatment

Clinical professor and chief physician Søren Gregersen from Aarhus University and Steno Diabetes Center Aarhus has received a grant of 7.6 million DKK from the Plant Fund for a research project that will investigate the effects of blueberries and oats in the treatment of type 2 diabetes.

A new research project, called BioDiaMi, will examine how plant-based foods can affect cholesterol levels and reduce inflammation in patients with diabetes.
A new research project, called BioDiaMi, will examine how plant-based foods can affect cholesterol levels and reduce inflammation in patients with diabetes. Photo: Steno Diabetes Center Aarhus.

In his research, clinical professor Søren Gregersen studies, among other things, how different foods and supplements can help prevent and treat type 2 diabetes.

A new research project, called BioDiaMi, will examine how plant-based foods can affect cholesterol levels and reduce inflammation in patients with diabetes. A total of 450 patients will participate in the study, which will span three months. During the study, participants will consume drinks containing either blueberries, oats, a combination of both, or a placebo.

In Denmark’s healthcare system, an increasing number of patients are being diagnosed with type 2 diabetes, while medication costs are rising significantly. Professor Niels Jessen, head of research at Steno Diabetes Center Aarhus, sees great potential in the project:

“We all need to change how we eat, and that's not necessarily a bad thing. Increased focus on green transition also obligates the healthcare system, and there are many unexplored medical opportunities in diet. We hope that the research will contribute to the development of plant-based supplements as a sustainable and safe treatment option for patients with diabetes and heart disease,” he says.

The project is part of a broader vision to develop sustainable, plant-based treatment options that can reduce rising medication costs, address the growing prevalence of type 2 diabetes, and generally promote a healthier lifestyle. The research is being conducted in close collaboration with Örebro University Hospital in Sweden.

This text is based on a press release from Steno Diabetes Center Aarhus.

Contact

Chief physician and clinical professor Søren Gregersen
Aarhus University, Department of Clinical Medicine and
Steno Diabetes Center Aarhus
Email: soeren.gregersen@aarhus.rm.dk

Head of research and professor Niels Jessen
Aarhus University, Department of Clinical Medicine and
Steno Diabetes Center Aarhus
Phone: +45 28 59 63 52
Email: niels.jessen@biomed.au.dk